Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy:
Headquarters:
United States of America
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
2016 (9 years)
Address:
1200 AVENUE OF THE AMERICAS; SUITE 200; NEW YORK CITY, NEW YORK 10036, US
At a glanceHIGH
spending power
